Siiltibcy is used to help detect infection and disease caused by Mycobacterium tuberculosis in adults and children aged 4 weeks and older. Siiltibcy contains the active substances rdESAT-6 and rCFP-10, two proteins from the M. tuberculosis bacterium.
Therapeutic Indication
### Therapeutic indication Diagnosis of infection with Mycobacterium tuberculosis.
Therapeutic Area (MeSH)
ATC Code
V04CF
ATC Item
结核诊断药
Pharmacotherapeutic Group
Tuberculosis diagnostics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10) | N/A | mycobacterium tuberculosis derived antigens (rdesat‑6 and rcfp‑10) |
EMA Name
Siiltibcy
Medicine Name
Siiltibcy
Aliases
N/ANo risk management plan link.
